SEATTLE--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will participate in a panel entitled “Delivering on the Promise of Antibody Therapies for Cancer” on Wednesday, December 12, 2007 at 3:30 p.m. Eastern Time as part of the RBC Capital Markets 2007 Healthcare Conference being held at The Westin New York at Times Square Hotel in New York City. The panel discussion will be moderated by Jason Kantor, Ph.D., Senior Biotechnology Analyst at RBC Capital Markets.
